miR-16-1-3p and miR-16-2-3p, targeting the FGFR2 and decrease angiogenesis, cell migration, and neural outgrowth, and promote cancer metastasis in Osteosarcoma (OS) and thus their upregulation sensitizes the cells to radiotherapy [28]. The gene discussed is FGFR2; the disease is cancer.